Boston, USA
4th American Drug Safety & Risk Management Conference 2026
he world's greatest minds in drug safety, pharmacovigilance, emerging technologies and innovation strategy coming together to discuss the future of PV and Risk Management, as part of our Pharmacovigilance World Tour 2026
KEY INFORMATION
80+
participants
20+
speakers
2
days
10+
hours of networking
15+
roundtable discussions
What to expect
Our prestigious 4th American Drug Safety & Risk Management Conference 2026, a cornerstone of our Pharmacovigilance World Tour.
- Join America’s Leading Drug Safety Professionals
- Gain insights into the most pressing issues facing drug safety today.
- Discuss the vision for 2027 and lessons of 2026
- Listen to the most crucial current topics selected & presented by industry leaders
- Enjoy education & networking focused event in a non-vendor-driven environment.
- Create lasting work groups and friendships with the possibility of meeting regularly on the next stops of our world tour
Target audience
You will spend time with:
- Pharmacovigilance Executives
- Regulatory Affairs Professionals
- Quality Assurance Specialists
- Drug Safety Officers
- Clinical Research Leaders
- VPs, Global Heads and Senior Directors of:
- Drug Safety
- Pharmacovigilance
- Risk Management
- Signal Detection
- Regulatory & Compliance
- Post-market research
- PV audit
- Digitization
- Automation
- Operations
EVENT speakers
Bikram Kabir
Senior Director - Global Safety Officer
Alkermes
Kapil Bhutada
Head of Pharmacovigilance Safety Operation and Compliance
AskBio
Vasu Miduturu
Director, Pharmacovigilance Operations
Tango Therapeutics
Samy Rabb
Senior Manager REMS Operations
TEVA
Abdul Rahim
Founder
Alwis
Hilary Yiokarinis
Director of Quality
Ultragenyx
Mamatha Chandrashekar
Safety Systems Program Lead
CSL
Peter Henstock
Machine Learning Group Leader
Incyte
Event HIGHLIGHTS

Visionary Keynotes

In-Depth Panels

Strategic Roundtables

Case Studies

Workshops

Networking
Key takeaways
Strengthening Risk
Mitigation Strategies
Mitigation Strategies
Tech Innovation: Digital Solutions for Risk Management
Evolving REMS Programs & Regulatory Expectations
Risk-Based Decision Making in Pharmacovigilance
AI: The Future of Safety Monitoring
Risk Communication & Stakeholder Collaboration
Post-Market Risk Management Best Practices
Future of REMS & Global Risk Management Regulations
The Next Decade of REMS & Risk Management
The Power of Cross-Functional Collaboration in PV
Enhancing PV Operations with AI & Automation
AI-Driven Signal Detection & Risk Prediction
The Business Case for AI in Pharmacovigilance
Optimizing Safety Signal Management through Collaboration
The Role of Real-World Evidence
Everything you need to know about This event in one spot.
Check out our event overview and agenda and discover 4th American Drug Safety & Risk Management Conference 2026
PAST AND PRESENT
Our valued partners
TESTIMONIALS
What an excellent 2-day event connecting with friends and industry colleagues, old and new. There was plenty to digest, lots of learnings and take home messages whilst we shared best practices. Looking forward to the next one!
★★★★★ Rated 5 out of 5
Nick Nikberg
Senior Pharmacovigilance Professional, Astra Zeneca
Thanks to the 9th Global Pharmacovigilance & RWE Forum speakers, for sharing their knowledge and experience. It was a great first Pharmacovigilance conference and a good chance to meet more like-minded people in the industry.
★★★★★ Rated 5 out of 5
Cláudia Meneses
Senior Pharmacovigilance Officer, Sanofi
A huge shout out to Why Summits for the terrific organization, bringing all these talented people together. Great minds, great conversations, great topics. Buckling up for the next 😄.
★★★★★ Rated 5 out of 5
Erika Barbarosie
Associate Director PV Compliance, Gilead Sciences
I have thoroughly enjoyed the past 2 days of networking with my colleagues and industry professionals. Thank you to Why Summits for wonderful organisation!
★★★★★ Rated 5 out of 5
Lewis Atkinson
Director of Business Development EMEA, IQVIA
The pragmatic discussions truly reflected ground realities, and the practical tips provided were invaluable. Kudos to the organiser Why Summits for the excellent choice of topics and for bringing together the experts to address the real-world challenges in utilizing real-world evidence for patient safety.
★★★★★ Rated 5 out of 5
Sanjeev Srivastav
Signal Management Lead, BioNTech
Really enjoyed the Pharmacovigilance & RWE Forum by Why Summits! What I loved most, is how friendly, collaborative and intimate the PV community really is. This is of course great to see, as a vendor, but more so a potential patient receiving the outputs of this heroic work!
★★★★★ Rated 5 out of 5
Souhail Debaghi
Director of Sales, TriNetX
“Always Be curious”
Why is this event right for you?
f you’re navigating the rapidly evolving intersection of pharmacovigilance and risk management, this conference offers the clarity, expertise, and connections you need. Whether you’re exploring how to strengthen pharmacovigilance risk management across safety operations, aligning with global regulatory requirements, or upskilling your team for an evolving safety landscape – this event delivers real-world insights from those leading the change.
Event partners
At Alwis Group, we’re pioneering AI-driven solutions for the healthcare and pharmaceutical industries. Our innovative tools are transforming pharmacovigilance, enhancing drug safety monitoring, and streamlining regulatory compliance. Our suite of products includes: ReTrans Enterprise: AI-powered literature surveillance ReTrans Extension: Browser plugin for real-time safety data analysis ScoMed: Intelligent medical literature scoring * ZiNex: Advanced medical document processing ZiQuel: AI-driven quality complaint management ZiTrack: Smart inbound receipt management We’re committed to improving patient safety and operational efficiency through cutting-edge technology. Our solutions reduce costs, minimize errors, and accelerate processes, allowing healthcare professionals to focus on what matters most – patient care.
Synapmed is a science-led, AI-native, full-service CRO transforming drug safety, compliance, and clinical development across the product lifecycle. The organization supports programs from pre-clinical through post-marketing across 40+ countries, operating in 60+ languages, and spanning ten plus therapeutic and rare-disease areas. With ISO-certified quality systems and a unified, inspection-ready operating model, Synapmed integrates clinical operations, regulatory affairs, pharmacovigilance, medical affairs, real-world evidence, and market access within a single connected platform, ensuring end-to-end traceability, auditability, and regulatory compliance across all deliverables. In parallel, Synapmed is pioneering the future of medical AI by contributing real-world, high-impact use cases to the training of one of the world’s most advanced large language models. We have recently supported a top-20 global pharmaceutical company in analyzing data from 50,000+ patients across 11 rare diseases, using AI to uncover treatment and biomarker patterns and enable up to 60% faster, data-driven decision-making.
Event registration
PHARMA & BIOTECH
REGISTRATION
$
2349
-
Access to all conference sessions
-
Access to all networking activities during the conference
-
Conference materials
-
Coffee breaks with snacks and refreshments
-
Networking lunch
SOLUTION-PROVIDERS & VENDORS
REGISTRATION
$
3049
-
Access to all conference sessions
-
Access to all networking activities during the conference
-
Conference materials
-
Coffee breaks with snacks and refreshments
-
Networking lunch
BECOME A PARTNER
OF this EVENT-
Present on the Main Stage
-
Hold an exhibit at this event
-
Showcase your Brand in Marketing Material
-
Gain exposure through alternative partnership benefits
Position Your Brand Where PV & Emerging Technologies Take Shape.
Get in front of the teams that manage pharma’s biggest programs. Explore sponsorship and exhibition opportunities at 4th American Drug Safety & Risk Management Conference 2026.
Our Past Sponsors
upcoming Events
- Pharmacovigilance
3rd Future of PV 2026
Date: June 9-10, 2026Location: Basel, Switzerland
World’s greatest minds in drug safety, pharmacovigilance, data analysis, reporting, government policy, and innovative technology united under one roof.
- Pharmacovigilance
3rd Global Drug Safety & PV Outsourcing Summit 2026
Date: September 29-30, 2026Location: Hyderabad
World’s greatest minds in drug safety, pharmacovigilance, data analysis, reporting, government policy, and innovative technology united under one roof.
- Pharmacovigilance
5th AMERICA DRUG SAFETY & AI 2026
Date: December 2-3, 2026Location: San Diego, USA
World’s greatest minds in drug safety, pharmacovigilance, data analysis, reporting, government policy, and innovative technology united under one roof.
- Pharmacovigilance
4th American Drug Safety & Risk Management Conference 2026
Date: December 8-9, 2026Location: Boston, USA
World’s greatest minds in drug safety, pharmacovigilance, data analysis, reporting, government policy, and innovative technology united under one roof.